Bellicum Pharmaceuticals, Inc. Gains 80.83%
Wed, Aug 23, 2023 at 07:04 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.5, a gain of 80.8%. On Wed, Aug 23, 2023, BLCM:NASDAQ hit a New 2-Week High of $0.5. From Wed, Aug 09, 2023, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Mon, May 08, 2023 at $1.31 with a volume of 100M+.
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- VCI Global Limited (VCIG:NASDAQ), 84%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 80.83%
- Mullen Automotive Inc. (MULN:NASDAQ), 68.07%
- AgileThought Inc. (AGIL:NASDAQ), 61.18%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 38.33%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 33.72%
- Apellis Pharmaceuticals, Inc. (APLS:NASDAQ), 30.17%
- One Stop Systems, Inc. (OSS:NASDAQ), 29.52%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 29.17%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 28.5%